SOLV 8-K 2026-07-20

Solventum Corp (SOLV) 8-K dated 2026-07-20 — accession 0001964738-26-000038. This URL is the filing, not the SOLV hub.

Solventum Corp (SOLV) is a medical instruments & supplies company listed on NYSE.

Solventum Corp filed a 8-K on 2026-07-20. Accession 0001964738-26-000038.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SOLV revenue for 2025-12-31 was $8.32B. Net income was $1.56B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.

Not investment advice. The SOLV SEC hub lists recent forms. The stock page is the research view.